trimetazidine has been researched along with abemaciclib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, YZ; Jin, X; Ma, D; Peng, WT; Shao, ZM; Xu, XE; Yang, YS | 1 |
1 other study(ies) available for trimetazidine and abemaciclib
| Article | Year |
|---|---|
Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer.
Topics: Acetyl-CoA C-Acyltransferase; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Humans; Protein Kinase Inhibitors; Trimetazidine; Triple Negative Breast Neoplasms | 2023 |